| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |